Back

Close

30 August 2025 (13:25 - 13:30)
Organised by: Logo
Congress Presentation Part of: Therapy in action: optimising heart failure care with SGLT2 inhibitors for outpatients Chronic Heart Failure Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor B. Bozkurt (Houston, US)
Slides
Presentation thumbnail
Why still talk about implementation of SGLT2 inhibitors?
Professor B. Bozkurt (Houston, US)
Presentation thumbnail
What are the barriers we need to break?
Professor P. Campbell (Newry, GB)
Presentation thumbnail
How do we identify patients with HFpEF?
Doctor C. Saldarriaga (Medellin, CO)
Presentation thumbnail
What are the wider benefits of SGLT2 inhibitors for cardio-renal-metabolic conditions?
Professor N. Marx (Aachen, DE)

Access the full session

Session thumbnail
Therapy in action: optimising heart failure care with SGLT2 inhibitors for outpatients
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 13:25 CET
You may be interested in
thumbnail
Congress Session
Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?
30 August 2025
thumbnail
Congress Presentation
Closure of atrial septal defect: what to consider – discussion.
26 August 2022
thumbnail
Congress Session
Molecular approaches to the treatment of pulmonary hypertension
27 August 2023
thumbnail
Congress Presentation
Practical considerations for the use of GLP-1 RAs in the clinic.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources